Adhera Therapeutics, Inc.

Adhera Therapeutics, Inc. Share · US00687E4061 (OTC) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Adhera Therapeutics, Inc.
No Price
Closing Price OTC 30.04.2026: 0,0001 USD
30.04.2026 20:00
Current Prices from Adhera Therapeutics, Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
ATRX
USD
30.04.2026 20:00
0,0001 USD
0,00 USD
Company Profile for Adhera Therapeutics, Inc. Share
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

Company Data

Name Adhera Therapeutics, Inc.
Company Adhera Therapeutics, Inc.
Website https://adherathera.com
Primary Exchange OTC UTC
ISIN US00687E4061
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Andrew Albert Kucharchuk
Country United States of America
Currency USD
Employees 0,0 T
Address 8000 Innovation Parkway, 70820 Baton Rouge
IPO Date 1993-12-07

Stock Splits

Date Split
06.10.2022 1:20
03.08.2017 1:10
23.12.2011 1:10
22.07.2010 1:4

ID Changes

Date From To
09.10.2018 MRNA ATRX

Ticker Symbols

Name Symbol
Over The Counter ATRX
More Shares
Investors who hold Adhera Therapeutics, Inc. also have the following shares in their portfolio:
ABN AMRO BK 24/UND.FLRMTN
ABN AMRO BK 24/UND.FLRMTN Bond
FlexiInternational Software Inc.
FlexiInternational Software Inc. Share